Tempus Priority Study: A Pan-tumor Observational Study

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

October 19, 2026

Study Completion Date

October 19, 2030

Conditions
Breast CancerProstate CancerBladder CancerLung CancerBrain CancerPancreatic CancerOvarian CancerFallopian Tube CancerPeritoneal CancerCancer of LiverCancer of ColonCancer of Head and NeckCancer of StomachCancer of Gastrointestinal TractCancer of RectumCancer of EsophagusCancer of SkinCancer of CervixCancer of KidneyCancer of LarynxCancer of EndometriumCancer of the Bile DuctCancer of VulvaCancer of Bone and Connective TissueLeukemiaLymphomaSpinal Cord Cancer
Interventions
OTHER

Observation

No Intervention

Trial Locations (2)

75390

UT Southwestern, Dallas

77030

Baylor College of Medicine, Houston

All Listed Sponsors
lead

Tempus AI

INDUSTRY